Results 111 to 120 of about 1,727,469 (168)

One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19. [PDF]

Front Public Health, 2022
Chang AY, Aaby P, Avidan MS, Benn CS, Bertozzi SM, Blatt L, Chumakov K, Khader SA, Kottilil S, Nekkar M, Netea MG, Sparrow A, Jamison DT.   +12 more
europepmc   +1 more source

Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021. [PDF]

Lancet Glob Health, 2022
Mirzoev A, Macklin GR, Zhang Y, Mainou BA, Sadykova U, Olsavszky VS, Huseynov S, Ruziev M, Saidzoda F, Bobokhonova M, Mach O.   +10 more
europepmc   +1 more source

A short review on poliomyelitis: types, transmission, diagnosis, prevention, treatment

Journal of Contemporary Pharmacy
This research is focused on the impact of poliomyelitis in current era. It also explores strategies for its prevention and control. The study utilizes qualitative research methods to comprehensively explain and support interpretive goals. Secondary data
Ayna Marzia, Liaqat Ali
doaj   +2 more sources

Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence during Roll-Out of Type-2 Novel Oral Polio Vaccine [PDF]

Vaccines (Basel)
Peak CM, Lyons H, Voorman A, Gray EJ, Cooper LV, Blake IM, Hawes K, Bandyopadhyay AS.   +7 more
europepmc   +2 more sources

Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. [PDF]

Euro Surveill, 2022
Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, Levi N, Weiss L, Aguvaev I, Cohen Z, Kestin K, Vasserman R, Elul M, Fratty IS, Geva M, Wax M, Erster O, Yishai R, Hecht-Sagie L, Alroy-Preis S, Mendelson E, Weil M.   +21 more
europepmc   +1 more source

Association of Paralytic Disease with Oral Polio Vaccines [PDF]

Summary -- I. Current Poliomyeliti Morbidity Trends -- II. Routine Surveillance-1964 -- Supplement: Assoication of Paralytic Disease with Oral Polio Vaccines: I. Press Release;II.

core  

Co-administration of Oral Cholera Vaccine With Oral Polio Vaccine Among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference. [PDF]

Clin Infect Dis, 2023
Islam MT, Date K, Khan AI, Bhuiyan TR, Khan ZH, Ahmed S, Hossain M, Khaton F, Zaman K, McMillan NAJ, Anand A, An Q, Zhang C, Weldon WC, Yu A, Luby S, Qadri F.   +16 more
europepmc   +1 more source

Oral Polio Vaccine Campaigns May Reduce the Risk of Death from Respiratory Infections. [PDF]

Vaccines (Basel), 2021
Nielsen S, Sujan HM, Benn CS, Aaby P, Hanifi SMA.   +4 more
europepmc   +1 more source

Co-Administration of Novel Oral Polio Vaccine Type 2 and Bivalent Oral Polio Vaccine: Current Evidence, Challenges, and Implications for the Polio Eradication Endgame. [PDF]

Infect Drug Resist
Bateyi Mustafa SH, Rodrigue TP, Raoul RZ, Dominique BB.   +3 more
europepmc   +1 more source

Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau. [PDF]

Open Forum Infect Dis, 2022
Fisker AB, Martins JSD, Nanque LM, Jensen AM, Ca EJC, Nielsen S, Martins CL, Rodrigues A.   +7 more
europepmc   +1 more source